We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Quest Diagnostics Completes Acquisition of Clinical Outreach Operations of Dignity Health
News

Quest Diagnostics Completes Acquisition of Clinical Outreach Operations of Dignity Health

Quest Diagnostics Completes Acquisition of Clinical Outreach Operations of Dignity Health
News

Quest Diagnostics Completes Acquisition of Clinical Outreach Operations of Dignity Health

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Quest Diagnostics Completes Acquisition of Clinical Outreach Operations of Dignity Health"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Quest Diagnostics announced that it has completed the previously announced acquisition of lab-related clinical outreach service operations of Dignity Health, a hospital system based in California.

Quest Diagnostics will perform testing for the acquired operations through its clinical laboratories in West Hills and Sacramento, Calif., and Las Vegas, Nevada. The acquisition includes patient service centers and associated business in parts of California and Nevada. Dignity Health's hospital-based laboratories are not included in the sale. Additional terms were not disclosed.

Quest Diagnostics continues to expect the transaction to be neutral to adjusted earnings in 2013 and modestly accretive to earnings per share in 2014. The company also expects it to contribute about half a percentage point to consolidated revenues annually.

The acquisition, which is the company's third of a laboratory business in 2013, is consistent with the five-point strategy described by Quest Diagnostics late last year. This strategy includes delivering disciplined capital deployment and driving one to two percent in growth per year through strategically aligned fold-in acquisitions. In May, the company announced it had acquired the toxicology and clinical laboratory business of medical center operator Concentra, a subsidiary of Humana Inc. In January, the company completed the acquisition of the clinical and anatomic-pathology outreach laboratory businesses of Massachusetts-based UMass Memorial Medical Center.

Advertisement